| UniProt ID | OGFR_HUMAN | |
|---|---|---|
| UniProt AC | Q9NZT2 | |
| Protein Name | Opioid growth factor receptor | |
| Gene Name | OGFR | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 677 | |
| Subcellular Localization | Cytoplasm. Nucleus. The OGF/OGFR complex is probably translocated to the nucleus. | |
| Protein Description | Receptor for opioid growth factor (OGF), also known as Met-enkephalin. Seems to be involved in growth regulation.. | |
| Protein Sequence | MDDPDCDSTWEEDEEDAEDAEDEDCEDGEAAGARDADAGDEDEESEEPRAARPSSFQSRMTGSRNWRATRDMCRYRHNYPDLVERDCNGDTPNLSFYRNEIRFLPNGCFIEDILQNWTDNYDLLEDNHSYIQWLFPLREPGVNWHAKPLTLREVEVFKSSQEIQERLVRAYELMLGFYGIRLEDRGTGTVGRAQNYQKRFQNLNWRSHNNLRITRILKSLGELGLEHFQAPLVRFFLEETLVRRELPGVRQSALDYFMFAVRCRHQRRQLVHFAWEHFRPRCKFVWGPQDKLRRFKPSSLPHPLEGSRKVEEEGSPGDPDHEASTQGRTCGPEHSKGGGRVDEGPQPRSVEPQDAGPLERSQGDEAGGHGEDRPEPLSPKESKKRKLELSRREQPPTEPGPQSASEVEKIALNLEGCALSQGSLRTGTQEVGGQDPGEAVQPCRQPLGARVADKVRKRRKVDEGAGDSAAVASGGAQTLALAGSPAPSGHPKAGHSENGVEEDTEGRTGPKEGTPGSPSETPGPSPAGPAGDEPAESPSETPGPRPAGPAGDEPAESPSETPGPRPAGPAGDEPAESPSETPGPSPAGPTRDEPAESPSETPGPRPAGPAGDEPAESPSETPGPRPAGPAGDEPAESPSETPGPSPAGPTRDEPAKAGEAAELQDAEVESSAKSGKP | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 1 | Acetylation | -------MDDPDCDS -------CCCCCCCC | 13.72 | 19413330 | |
| 8 | Phosphorylation | MDDPDCDSTWEEDEE CCCCCCCCCCCCCHH | 41.57 | 26552605 | |
| 9 | Phosphorylation | DDPDCDSTWEEDEED CCCCCCCCCCCCHHH | 24.52 | 26552605 | |
| 45 | Phosphorylation | AGDEDEESEEPRAAR CCCCCCCCCCCCCCC | 45.25 | 20873877 | |
| 54 | Phosphorylation | EPRAARPSSFQSRMT CCCCCCCCHHHHHHH | 37.93 | 26434776 | |
| 55 | Phosphorylation | PRAARPSSFQSRMTG CCCCCCCHHHHHHHC | 29.95 | 25106551 | |
| 58 | Phosphorylation | ARPSSFQSRMTGSRN CCCCHHHHHHHCCCC | 23.24 | 26434776 | |
| 158 (in isoform 2) | Ubiquitination | - | 55.14 | 21890473 | |
| 158 (in isoform 1) | Ubiquitination | - | 55.14 | 21890473 | |
| 158 | Ubiquitination | LREVEVFKSSQEIQE EEEEEEHHCCHHHHH | 55.14 | 21906983 | |
| 171 | Phosphorylation | QERLVRAYELMLGFY HHHHHHHHHHHHHHH | 10.07 | 22817900 | |
| 178 | Phosphorylation | YELMLGFYGIRLEDR HHHHHHHHCEEEECC | 15.16 | 22817900 | |
| 187 | Phosphorylation | IRLEDRGTGTVGRAQ EEEECCCCCCHHCHH | 30.49 | - | |
| 189 | Phosphorylation | LEDRGTGTVGRAQNY EECCCCCCHHCHHHH | 21.45 | - | |
| 196 | Phosphorylation | TVGRAQNYQKRFQNL CHHCHHHHHHHHHHC | 11.88 | 22817900 | |
| 198 | Ubiquitination | GRAQNYQKRFQNLNW HCHHHHHHHHHHCCC | 44.83 | 27667366 | |
| 218 (in isoform 2) | Ubiquitination | - | 41.06 | 21890473 | |
| 218 | Ubiquitination | LRITRILKSLGELGL HHHHHHHHHHHHHCH | 41.06 | 23000965 | |
| 218 (in isoform 1) | Ubiquitination | - | 41.06 | 21890473 | |
| 240 | Phosphorylation | VRFFLEETLVRRELP HHHHHHHHHHHHCCC | 22.60 | 25599653 | |
| 252 | Phosphorylation | ELPGVRQSALDYFMF CCCCCHHHHHHHHHH | 21.89 | 24043423 | |
| 256 | Phosphorylation | VRQSALDYFMFAVRC CHHHHHHHHHHHHHC | 9.59 | 24043423 | |
| 283 | Ubiquitination | EHFRPRCKFVWGPQD HHHHCCCEEEECCHH | 44.20 | - | |
| 283 | Acetylation | EHFRPRCKFVWGPQD HHHHCCCEEEECCHH | 44.20 | 25953088 | |
| 291 | Ubiquitination | FVWGPQDKLRRFKPS EEECCHHHHHCCCCC | 38.35 | 21963094 | |
| 291 (in isoform 1) | Ubiquitination | - | 38.35 | 21890473 | |
| 291 (in isoform 2) | Ubiquitination | - | 38.35 | 21890473 | |
| 291 | Acetylation | FVWGPQDKLRRFKPS EEECCHHHHHCCCCC | 38.35 | 21339330 | |
| 296 | Ubiquitination | QDKLRRFKPSSLPHP HHHHHCCCCCCCCCC | 42.02 | 22817900 | |
| 298 | Phosphorylation | KLRRFKPSSLPHPLE HHHCCCCCCCCCCCC | 45.13 | 23401153 | |
| 299 | Phosphorylation | LRRFKPSSLPHPLEG HHCCCCCCCCCCCCC | 55.22 | 20873877 | |
| 307 | Phosphorylation | LPHPLEGSRKVEEEG CCCCCCCCCCCCCCC | 21.39 | 23186163 | |
| 309 | Sumoylation | HPLEGSRKVEEEGSP CCCCCCCCCCCCCCC | 56.55 | - | |
| 309 | Sumoylation | HPLEGSRKVEEEGSP CCCCCCCCCCCCCCC | 56.55 | - | |
| 309 | Ubiquitination | HPLEGSRKVEEEGSP CCCCCCCCCCCCCCC | 56.55 | 24816145 | |
| 315 | Phosphorylation | RKVEEEGSPGDPDHE CCCCCCCCCCCCCCC | 29.05 | 29255136 | |
| 324 | Phosphorylation | GDPDHEASTQGRTCG CCCCCCHHCCCCCCC | 20.48 | 23927012 | |
| 325 | Phosphorylation | DPDHEASTQGRTCGP CCCCCHHCCCCCCCC | 41.93 | 23927012 | |
| 329 | Phosphorylation | EASTQGRTCGPEHSK CHHCCCCCCCCCCCC | 28.74 | - | |
| 335 | Phosphorylation | RTCGPEHSKGGGRVD CCCCCCCCCCCCCCC | 31.19 | 20860994 | |
| 349 | Phosphorylation | DEGPQPRSVEPQDAG CCCCCCCCCCCCCCC | 37.20 | 29255136 | |
| 361 | Phosphorylation | DAGPLERSQGDEAGG CCCCCCHHCCCCCCC | 29.19 | 30266825 | |
| 378 | Phosphorylation | EDRPEPLSPKESKKR CCCCCCCCHHHHHHH | 44.64 | 29255136 | |
| 382 | Phosphorylation | EPLSPKESKKRKLEL CCCCHHHHHHHHHHH | 49.99 | 23401153 | |
| 384 | Ubiquitination | LSPKESKKRKLELSR CCHHHHHHHHHHHHH | 65.13 | 24816145 | |
| 386 | Ubiquitination | PKESKKRKLELSRRE HHHHHHHHHHHHHCC | 56.01 | 27667366 | |
| 390 | Phosphorylation | KKRKLELSRREQPPT HHHHHHHHHCCCCCC | 21.66 | 24117733 | |
| 397 | Phosphorylation | SRREQPPTEPGPQSA HHCCCCCCCCCCCCH | 62.59 | 29978859 | |
| 403 | Phosphorylation | PTEPGPQSASEVEKI CCCCCCCCHHHHHHH | 36.57 | 25159151 | |
| 405 | Phosphorylation | EPGPQSASEVEKIAL CCCCCCHHHHHHHHH | 47.63 | 25262027 | |
| 420 | Phosphorylation | NLEGCALSQGSLRTG CCCCHHHCCCCCCCC | 17.61 | 17525332 | |
| 423 | Phosphorylation | GCALSQGSLRTGTQE CHHHCCCCCCCCCCC | 13.67 | 28450419 | |
| 426 | Phosphorylation | LSQGSLRTGTQEVGG HCCCCCCCCCCCCCC | 50.29 | 22817900 | |
| 428 | Phosphorylation | QGSLRTGTQEVGGQD CCCCCCCCCCCCCCC | 22.42 | 22817900 | |
| 454 | Acetylation | LGARVADKVRKRRKV CCHHHHHHHHHHCCC | 33.91 | 30591015 | |
| 468 | Phosphorylation | VDEGAGDSAAVASGG CCCCCCCCHHHHCCC | 19.74 | 23927012 | |
| 473 | Phosphorylation | GDSAAVASGGAQTLA CCCHHHHCCCCCEEE | 31.03 | 30278072 | |
| 478 | Phosphorylation | VASGGAQTLALAGSP HHCCCCCEEEECCCC | 17.29 | 23927012 | |
| 484 | Phosphorylation | QTLALAGSPAPSGHP CEEEECCCCCCCCCC | 16.57 | 29255136 | |
| 488 | Phosphorylation | LAGSPAPSGHPKAGH ECCCCCCCCCCCCCC | 52.41 | 23401153 | |
| 496 | Phosphorylation | GHPKAGHSENGVEED CCCCCCCCCCCCCCC | 31.66 | 28985074 | |
| 508 | Phosphorylation | EEDTEGRTGPKEGTP CCCCCCCCCCCCCCC | 69.56 | 26074081 | |
| 514 | Phosphorylation | RTGPKEGTPGSPSET CCCCCCCCCCCCCCC | 26.10 | 30266825 | |
| 517 (in isoform 2) | Phosphorylation | - | 26.84 | 25137130 | |
| 517 | Phosphorylation | PKEGTPGSPSETPGP CCCCCCCCCCCCCCC | 26.84 | 19664994 | |
| 519 (in isoform 2) | Phosphorylation | - | 56.66 | 25137130 | |
| 519 | Phosphorylation | EGTPGSPSETPGPSP CCCCCCCCCCCCCCC | 56.66 | 30266825 | |
| 521 (in isoform 2) | Phosphorylation | - | 37.57 | 25137130 | |
| 521 | Phosphorylation | TPGSPSETPGPSPAG CCCCCCCCCCCCCCC | 37.57 | 30266825 | |
| 525 | Phosphorylation | PSETPGPSPAGPAGD CCCCCCCCCCCCCCC | 33.04 | 30266825 | |
| 525 (in isoform 2) | Phosphorylation | - | 33.04 | 25137130 | |
| 537 (in isoform 2) | Phosphorylation | - | 35.51 | 25137130 | |
| 537 | Phosphorylation | AGDEPAESPSETPGP CCCCCCCCCCCCCCC | 35.51 | 19664994 | |
| 539 (in isoform 2) | Phosphorylation | - | 64.48 | 25137130 | |
| 539 | Phosphorylation | DEPAESPSETPGPRP CCCCCCCCCCCCCCC | 64.48 | 23401153 | |
| 541 (in isoform 2) | Phosphorylation | - | 37.57 | 25137130 | |
| 541 | Phosphorylation | PAESPSETPGPRPAG CCCCCCCCCCCCCCC | 37.57 | 30266825 | |
| 557 | Phosphorylation | AGDEPAESPSETPGP CCCCCCCCCCCCCCC | 35.51 | 19664994 | |
| 557 (in isoform 2) | Phosphorylation | - | 35.51 | 25137130 | |
| 559 | Phosphorylation | DEPAESPSETPGPRP CCCCCCCCCCCCCCC | 64.48 | 30266825 | |
| 561 | Phosphorylation | PAESPSETPGPRPAG CCCCCCCCCCCCCCC | 37.57 | 30266825 | |
| 577 | Phosphorylation | AGDEPAESPSETPGP CCCCCCCCCCCCCCC | 35.51 | 30266825 | |
| 579 | Phosphorylation | DEPAESPSETPGPSP CCCCCCCCCCCCCCC | 64.48 | 30266825 | |
| 581 | Phosphorylation | PAESPSETPGPSPAG CCCCCCCCCCCCCCC | 37.57 | 30266825 | |
| 585 | Phosphorylation | PSETPGPSPAGPTRD CCCCCCCCCCCCCCC | 33.04 | 30266825 | |
| 590 | Phosphorylation | GPSPAGPTRDEPAES CCCCCCCCCCCCCCC | 50.24 | 23663014 | |
| 597 | Phosphorylation | TRDEPAESPSETPGP CCCCCCCCCCCCCCC | 35.51 | 23401153 | |
| 599 | Phosphorylation | DEPAESPSETPGPRP CCCCCCCCCCCCCCC | 64.48 | 23401153 | |
| 601 | Phosphorylation | PAESPSETPGPRPAG CCCCCCCCCCCCCCC | 37.57 | 23663014 | |
| 617 | Phosphorylation | AGDEPAESPSETPGP CCCCCCCCCCCCCCC | 35.51 | 19664994 | |
| 619 | Phosphorylation | DEPAESPSETPGPRP CCCCCCCCCCCCCCC | 64.48 | 30266825 | |
| 621 | Phosphorylation | PAESPSETPGPRPAG CCCCCCCCCCCCCCC | 37.57 | 30266825 | |
| 636 (in isoform 2) | Ubiquitination | - | 74.11 | - | |
| 637 | Phosphorylation | AGDEPAESPSETPGP CCCCCCCCCCCCCCC | 35.51 | 30266825 | |
| 639 | Phosphorylation | DEPAESPSETPGPSP CCCCCCCCCCCCCCC | 64.48 | 30266825 | |
| 641 | Phosphorylation | PAESPSETPGPSPAG CCCCCCCCCCCCCCC | 37.57 | 30266825 | |
| 645 | Phosphorylation | PSETPGPSPAGPTRD CCCCCCCCCCCCCCC | 33.04 | 30266825 | |
| 650 | Phosphorylation | GPSPAGPTRDEPAKA CCCCCCCCCCCCCCC | 50.24 | 29255136 | |
| 656 | Ubiquitination | PTRDEPAKAGEAAEL CCCCCCCCCCCHHHH | 68.58 | 23503661 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 378 | S | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of OGFR_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of OGFR_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| CDC37_HUMAN | CDC37 | physical | 22863883 | |
| FKBP5_HUMAN | FKBP5 | physical | 22863883 | |
| SHOT1_HUMAN | KIAA1598 | physical | 22863883 | |
| MAGD2_HUMAN | MAGED2 | physical | 22863883 | |
| TRAP1_HUMAN | TRAP1 | physical | 22863883 | |
| UBP7_HUMAN | USP7 | physical | 22863883 | |
| CDK4_HUMAN | CDK4 | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-315, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-315; SER-349 ANDSER-378, AND MASS SPECTROMETRY. | |
| "Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-378, AND MASSSPECTROMETRY. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-315, AND MASS SPECTROMETRY. | |
| "Large-scale phosphoproteome analysis of human liver tissue byenrichment and fractionation of phosphopeptides with strong anionexchange chromatography."; Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,Zou H., Gu J.; Proteomics 8:1346-1361(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-378, AND MASSSPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-349; SER-361; SER-378AND SER-484, AND MASS SPECTROMETRY. | |
| "Phosphorylation analysis of primary human T lymphocytes usingsequential IMAC and titanium oxide enrichment."; Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.; J. Proteome Res. 7:5167-5176(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-378, AND MASSSPECTROMETRY. | |
| "ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-420, AND MASSSPECTROMETRY. | |
| "Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-315, AND MASSSPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-315 AND SER-378, ANDMASS SPECTROMETRY. | |